Also trades as: MRK.DE (XETRA) · $vol 47M · MKKGY (OTC) · $vol 2M

$156.24

+6.53 (+4.36%)

Weekly Expected Move ±7.3%

$133 $145 $156 $168 $179

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $67.9B mcap · 435M float · 0.0001% daily turnover · Short 29% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$21.1B -0.3% ▼

5Y CAGR: +3.8%

Gross Profit

$11.9B -4.8% ▼

5Y CAGR: +2.1%

Operating Income

$4.1B +11.5% ▲

5Y CAGR: +6.4%

Net Income

$2.6B -6.1% ▼

5Y CAGR: +5.6%

EPS (Diluted)

$6.00 -6.1% ▼

5Y CAGR: +5.6%

EBITDA

$5.9B -0.3% ▼

5Y CAGR: +4.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.7B	$22.2B	$21.0B	$21.2B	$21.1B
YoY Growth	+12.3%	+12.9%	-5.6%	+0.8%	-0.3%
Cost of Revenue	$7.4B	$8.5B	$8.6B	$8.7B	$9.2B
Gross Profit	$12.3B	$13.7B	$12.4B	$12.5B	$11.9B
Gross Margin	62.7%	61.6%	59.2%	59.0%	56.4%
R&D Expenses	$2.4B	$2.5B	$2.4B	$2.3B	$2.4B
SG&A Expenses	$5.0B	$5.4B	$5.3B	$5.4B	$5.3B
Operating Expenses	$8.1B	$9.0B	$8.8B	$8.8B	$7.8B
Operating Income	$4.2B	$4.5B	$3.6B	$3.6B	$4.1B
Operating Margin	21.2%	20.1%	17.2%	17.2%	19.3%
Interest Expense	$277M	$208M	$272M	$292M	$262M
Income Before Tax	$3.9B	$4.3B	$3.5B	$3.5B	$3.3B
Tax Expense	$859M	$948M	$650M	$751M	$693M
Net Income	$3.1B	$3.3B	$2.8B	$2.8B	$2.6B
Net Margin	15.5%	15.0%	13.5%	13.1%	12.4%
EPS (Diluted)	$7.03	$7.65	$6.50	$6.39	$6.00
EBITDA	$5.9B	$6.3B	$5.7B	$6.0B	$5.9B
Shares Outstanding	435M	435M	435M	435M	435M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$5.3B	$5.4B	$5.3B	$5.3B	$5.3B	$5.2B	$5.2B	$5.4B
Cost of Revenue	$2.1B	$2.3B	$2.1B	$2.2B	$2.1B	$2.3B	$2.1B	$2.3B
Gross Profit	$3.1B	$3.1B	$3.1B	$3.0B	$3.2B	$3.0B	$3.1B	$3.2B
Gross Margin	59.7%	57.2%	59.6%	57.6%	60.4%	56.4%	59.7%	58.3%
R&D Expenses	$524M	$527M	$551M	$539M	$774M	$664M	$660M	$683M
SG&A Expenses	$1.4B	$1.0B	$1.5B	$1.5B	$1.5B	$1.5B	$1.5B	$1.3B
Operating Expenses	$2.0B	$2.3B	$2.1B	$2.1B	$2.0B	$2.2B	$2.1B	$2.0B
Operating Income	$1.1B	$824M	$1.0B	$891M	$1.2B	$781M	$996M	$1.2B
Operating Margin	20.8%	15.2%	19.1%	17.0%	23.0%	14.9%	19.3%	21.5%
Interest Expense	$89M	$59M	$78M	$79M	$148M	$121M	$104M	$137M
Income Before Tax	$1.0B	$808M	$956M	$829M	$1.1B	$401M	$872M	$639M
Tax Expense	$231M	$140M	$218M	$174M	$225M	$77M	$201M	$146M
Net Income	$809M	$667M	$735M	$652M	$902M	$319M	$663M	$489M
Net Margin	15.4%	12.3%	13.9%	12.4%	17.0%	6.1%	12.9%	9.0%
EPS (Diluted)	$1.86	$1.53	$1.69	$1.50	$2.07	$0.73	$1.52	$1.13
EBITDA	$1.6B	$1.4B	$1.5B	$1.4B	$2.0B	$1.7B	$1.5B	$1.7B
Shares Outstanding	435M	435M	435M	435M	436M	435M	435M	435M

MKGAF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet